The<unk> <unk>  trial , was a large-scale, randomized, multicenter, multinational trial conducted between 1999 and 2004. The trial compared the<unk>  of PCI versus optimal medical therapy as the initial treatment strategy in patients with stable angina and significant underlying coronary artery disease on cardiac catheterization.  The rates of death and MI did not differ between the two groups, but PCI was associated with an improvement in quality of life measures and anginal symptoms for up to 3 years.
Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
Appropriate use criteria for revascularization
TAVR Patient selection
Sudden cardiac death classification
Cardiac resynchronization therapy landmark trials
Atrial fibrillation cost-effectiveness of therapy
Saphenous Vein Graft Nomenclature
Coronary artery bypass surgery heart team approach to revascularization decisions